PBS Website Update - 1 April 2017
Page last updated: 1 April 2017
The Schedule of Pharmaceutical Benefits was updated on 1 April 2017 and the Summary of Changes can be found on the New, Amended and Deleted Items page.
The following updates have also been made to the PBS Website:
- Ex-manufacturer price - 1 April 2017
- Formulary Allocations - 1 April 2017
- Drugs subject to Price Disclosure - 1 April 2017
- Therapeutic Relativities - 1 April 2017
- 12.5% and 16% Price Reductions - 1 April 2017
- Listings on the PBS for Aboriginal and Torres Strait Islander people - 1 April 2017
- Advice for approved pharmacists supplying PBS medicines to patients in areas affected by Ex-Tropical Cyclone Debbie – March 2017 - 30 March 2017
- National Health Amendment (Pharmaceutical Benefits) Act 2017 - 29 March 2017
- Post-Market Review of the Use of Biologics in the Treatment of Severe Chronic Plaque Psoriasis – Public Consultation Process - 28 March 2017
- Brand Price Reductions and Savings to Patients – Disclosure Cycles - 27 March 2017
- Updated Dose and Cartridge Quantity Calculator’ for the Growth Hormone Program - 24 March 2017
- Public Summary Document (PSD) for pembrolizumab (NSCLC) - November 2016 PBAC meeting - 23 March 2017
- Additional PBAC Public Summary Documents - November 2016 meeting - 17 March 2017
- Chemotherapy Compounding Payment Scheme - Extension to the non-mandatory claiming period - 17 March 2017
- Drug Utilisation Sub Committee (DUSC) Outcome Statement- February 2017 meeting - 15 March 2017
- Access to Medicines Working Group (AMWG) - December 2016 meeting - 15 March 2017
- Confirmed 1 April 2017 prices – 2017 April cycle of Price Disclosure - 10 March 2017
- Recommendations made by the PBAC - November 2016 - 7 March 2017
- Chronic Obstructive Pulmonary Disorder (COPD) Review - Stakeholder Forum: 21 March 2017 - 6 March 2017
- PBAC Public Summary Documents - November 2016 meeting - 3 March 2017
- Drug Utilisation Sub Committee (DUSC) Utilisation Analysis Public Release Documents - 3 March 2017
